A Clinical Trial of Thread-embedding Therapy at Acupuncture Point for Simple Obesity

A Clinical Trial of Acupoint Thread-embedding Therapy for Simple Obesity

Thread-embedding Therapy has been used for treating Obesity in recent years. This research is aimed to observe the clinical effect of thread-embedding therapy in treating Simple Obesity. One hundred patients is planned to be enrolled in the research and receive a thread-embedding therapy. The level of BMI, serum triglyceride, cholesterol and fasting blood glucose will be adopted for evaluation before and after therapy.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

Each participant will receive thread-embedding therapy every two weeks, and eight times in all.Blood test will be taken at the beginning of the first week of the whole therapy, and at the end of the 8th therapy. During the periods of whole therapy, the participants shall follow diets control and physical exercise as the protocol described.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200032
        • Recruiting
        • Institute of Digestive Diseases of Longhua Hospital affiliate to Shanghai University of Traditional Chinese Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • patients with age from 18 to 60 years old;
  • patients with BMI≥ 24, meanwhile waist more than 85 cm (for male) or 80 cm (for female);
  • patients with diagnosed as central adiposity and/or Simple obesity according to the diagnosis criteria;
  • patients who is willing to cooperate with the test treatment and signed informed consent.

Exclusion Criteria:

  • Pregnant or lactating women;
  • patients who Syncope after acupuncture;
  • patients who present hypersensitivity reactions after acupoint-embedding therapy;
  • patients with serious heart, liver, kidney, brain and other diseases;
  • patients with severe primary diseases;
  • patients with psychiatric diseases;
  • patients who did not meet the criteria for the inclusion criteria while investigators find out during the trial;
  • participants who did not complete dietary control and physical exercise as the protocol described.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: participants received treatment
100 participants who are diagnosed as simple obesity under the standards of... are planned to enrolled in the trial. Each will receive Thread-embedding therapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change Body Weight
Time Frame: participants will receive Thread-embedding Therapy twice a week lasting for 16 weeks subsequently.8 times in all.
a 5 percent of loss of body weight will be judged as effective
participants will receive Thread-embedding Therapy twice a week lasting for 16 weeks subsequently.8 times in all.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effection on cholesterol
Time Frame: Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
a target examined by blood test, in order to compare the Lipid metabolism
Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
The effection on triglyceride
Time Frame: Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
a target examined by blood test, in order to compare the Lipid metabolism
Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
The effection on fasting blood glucose
Time Frame: Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.
to compare the level of glucose in order to get the message of improvement of blood glucose disorder by our therapy.
Therapy is the same as mentioned above. Participants will take blood test at the beginning of the first week of the therapy, and at the end of the 16th week.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 3, 2017

Primary Completion (Anticipated)

December 31, 2017

Study Completion (Anticipated)

March 31, 2018

Study Registration Dates

First Submitted

September 3, 2017

First Submitted That Met QC Criteria

October 26, 2017

First Posted (Actual)

October 30, 2017

Study Record Updates

Last Update Posted (Actual)

October 30, 2017

Last Update Submitted That Met QC Criteria

October 26, 2017

Last Verified

June 1, 2017

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Weight Loss

Clinical Trials on Thread-embedding Therapy

Subscribe